Radiation Oncology/Therapy: Page 3

Ratio Therapeutics to construct radiopharmaceutical facility

By AuntMinnie.com staff writers

Ratio Therapeutics has entered into an agreement with the Medical Innovation Technology Management division of Wasatch Group.

May 8, 2025

Accuray reports first CyberKnife treatments in Austria

Accuray is reporting the first CyberKnife treatments at CyberKnife Center Salzburg in Austria.

May 5, 2025

ARRS: Breast RT doesn't impact presence of breast arterial calcifications

By Kate Madden Yee

May 2, 2025

RaySearch launches v2025 RayStation

By AuntMinnie.com staff writers

The company is highlighting the integration of the autoplanning algorithm ECHO.

May 2, 2025

GE HealthCare expands radiation oncology portfolio

By AuntMinnie.com staff writers

AI technology will add new options for MR-guided radiotherapy workflows.

May 2, 2025

What is the best timing for PET scans after radiotherapy?

By Will Morton

Men should have prostate-specific membrane antigen PET scans about eight months after undergoing external beam radiotherapy for prostate cancer.

March 28, 2025

ASTRO vice chair highlights momentum for ROCR Act

By Amerigo Allegretto

Chris Corso, MD, PhD, from ASTRO discusses why the ROCR Act is needed to stabilize reimbursement for radiation oncologists in the U.S.

March 19, 2025

Consolidation reigns in radiation oncology

By Will Morton

Solo practices in radiation oncology dropped significantly between 2015 and 2023 while the number of large practices increased by more than half.

March 7, 2025

ASTRO: Shorter radiation course safe for breast reconstruction

By Amerigo Allegretto

Research presented at the ASTRO annual meeting shows that a shorter course of postmastectomy radiation combined with breast reconstruction is safe.

October 2, 2024

ASTRO: Timing key to adding immunotherapy to chemoradiation

By Amerigo Allegretto

Timing may be key when adding immunotherapy to chemoradiation for lung cancer treatment.

October 1, 2024

ASTRO: Black patients voice distrust in medical research

By Will Morton

Spiritual beliefs and a distrust of clinical research may partly explain why Black patients choose not to participate in cancer trials.

September 30, 2024

ASTRO: IMRT and proton therapy equally effective for prostate cancer

By Will Morton

Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer.

September 30, 2024

Previous Page

Page 3 of 464

Next Page